Osteoporosis during Continuous Androgen Deprivation: Influence of the Modality and Length of Treatment
- 1 December 2003
- journal article
- research article
- Published by Elsevier in European Urology
- Vol. 44 (6) , 661-665
- https://doi.org/10.1016/s0302-2838(03)00379-8
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- SKELETAL FRACTURE ASSOCIATED WITH ANDROGEN SUPPRESSION INDUCED OSTEOPOROSIS: THE CLINICAL INCIDENCE AND RISK FACTORS FOR PATIENTS WITH PROSTATE CANCERJournal of Urology, 2001
- Osteoporosis in older menClinical Cornerstone, 2000
- Determinants of Bone Density in Healthy Older Men With Low Testosterone LevelsThe Journals of Gerontology: Series A, 2000
- Epidemiology of Osteoporotic FracturesHormone Research in Paediatrics, 2000
- PROGRESSIVE OSTEOPOROSIS DURING ANDROGEN DEPRIVATION THERAPY FOR PROSTATE CANCERJournal of Urology, 2000
- Androgen deprivation therapy for prostate cancer results in significant loss of bone densityUrology, 1999
- Osteoporosis After Orchiectomy for Prostate CancerJournal of Urology, 1997
- Bone fractures associated with luteinizing hormone-releasing hormone agonists used in the treatment of prostate carcinomaCancer, 1997
- Decreased bone density in elderly men treated with the gonadotropin- releasing hormone agonist decapeptyl (D-Trp6-GnRH)Journal of Clinical Endocrinology & Metabolism, 1993
- Castrated Men Exhibit Bone Loss: Effect of Calcitonin Treatment on Biochemical Indices of Bone Remodeling*Journal of Clinical Endocrinology & Metabolism, 1989